MediciNova (MNOV US)

MediciNova, Inc. operates as a biopharmaceutical company. The Company acquires and develops small molecule therapeutics for the treatment of asthma and COPD, progressive multiple sclerosis, neuropathic pain, methamphetamine addiction, interstitial cystitis, and solid tumor cancers. MediciNova offers its products to the healthcare industry with a focus on the Unites States market.